Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSA Progression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03541850
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Who this might be right for
PSA Level Greater Than 0.03PSA ProgressionStage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7+2 more
Jonsson Comprehensive Cancer Center 92
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Large-scale testing (Phase 3)UnknownNCT00567580
What this trial is testing

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,792
Large-scale testing (Phase 3)Ended earlyNCT00514917
What this trial is testing

Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostatic Neoplasms
Sanofi 413
Not applicableStudy completedNCT00242060
What this trial is testing

Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy

Who this might be right for
Elevated PSAProstate Cancer
University Health Network, Toronto
Not applicableStudy completedNCT01763944
What this trial is testing

Carbohydrate Restriction and Prostate Cancer Growth

Who this might be right for
Prostate Cancer
Duke University 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Who this might be right for
Castration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more
OHSU Knight Cancer Institute 58
Large-scale testing (Phase 3)Looking for participantsNCT07052214
What this trial is testing

PSMA PET Combined With MRI for the Detection of PCa

Who this might be right for
PCAProstate CancerProstatic Neoplasm+6 more
Telix Pharmaceuticals (Innovations) Pty Limited 338
Testing effectiveness (Phase 2)Active Not RecruitingNCT01786265
What this trial is testing

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate Carcinoma
M.D. Anderson Cancer Center 310
Not applicableNot Yet RecruitingNCT06669273
What this trial is testing

Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI)

Who this might be right for
Suspected Prostate Cancer (increased PSA Level)
University Hospital, Clermont-Ferrand 70
Early research (Phase 1)Study completedNCT00148928
What this trial is testing

Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 25
Testing effectiveness (Phase 2)Study completedNCT00678054
What this trial is testing

Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
University of California, San Francisco 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04915508
What this trial is testing

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 165
Not applicableStudy completedNCT03881709
What this trial is testing

The Efficacy of Decision Support E-book for Prostate Biopsy Decision Making

Who this might be right for
Prostate-Specific Antigen
National Taipei University of Nursing and Health Sciences 110
Large-scale testing (Phase 3)Study completedNCT02673151
What this trial is testing

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

Who this might be right for
Prostate AdenocarcinomaPSA FailureRecurrent Prostate Carcinoma
Andrei Iagaru 61
Not applicableTemporarily pausedNCT06509919
What this trial is testing

Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate Cancer

Who this might be right for
Prostate Cancer
Shanghai Changzheng Hospital 1,600
Testing effectiveness (Phase 2)Ended earlyNCT03442556
What this trial is testing

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

Who this might be right for
ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more
University of Washington 18
Testing effectiveness (Phase 2)Study completedNCT00090363
What this trial is testing

ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
AstraZeneca 447
Testing effectiveness (Phase 2)Study completedNCT01171898
What this trial is testing

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Aragon Pharmaceuticals, Inc. 127
Not applicableActive Not RecruitingNCT03891732
What this trial is testing

MRI Prostate for Chinese Men Being Screened for Prostate Cancer

Who this might be right for
Prostate CancerPSAMRI
Chinese University of Hong Kong 690
Next Page